Sangamo Biosciences reported $16.49M in Selling and Administration Expenses for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Selling And Administration Expenses Change
Acceleron Pharma XLRN:US $ 35.47M 4.41M
Alnylam Pharmaceuticals ALNY:US $ 153.82M 1.08M
Amgen AMGN:US $ 1.38B 130M
Avrobio Inc AVRO:US 8.83M 474K
Bayer BAYN:GR 3.75B 226M
Biocryst Pharmaceuticals BCRX:US $ 26.32M 4.21M
Biogen BIIB:US $ 637.3M 42.3M
Biomarin Pharmaceutical BMRN:US $ 184.16M 9.84M
Bluebird Bio BLUE:US $ 78.58M 8.3M
Gilead Sciences GILD:US $ 1.34B 297M
GlaxoSmithKline GSK:LN 2.5B 183M
Intercept Pharmaceuticals ICPT:US $ 57.65M 1.62M
IONIS PHARMACEUT IONS:US $ 56.46M 4.74M
Johnson & Johnson JNJ:US $ 6.07B 641M
Karyopharm Therapeutics KPTI:US $ 36.53M 1.12M
Merk MRK:US $ 2.25B 376M
Novartis NOVN:VX 3.71B 190M
Omeros OMER:US $ 21.56M 3.51M
Pfizer PFE:US $ 2.79B 134M
Regulus Therapeutics RGLS:US $ 2.49M 10K
Sangamo Biosciences SGMO:US $ 16.49M 338K
Sarepta Therapeutics SRPT:US $ 72.35M 1.22M
Ultragenyx Pharmaceutical RARE:US $ 53.41M 152K
Vertex Pharmaceuticals VRTX:US $ 194.67M 2.59M
Ziopharm Oncology ZIOP:US $ 9.07M 842K